Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Implementing Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
    Optimizing Early Biomarker Testing to Guide Clinical Decision-Making in Colorectal Cancer Across Latin America
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Argentina, Brazil, Chile, Colombia, Mexico, Peru
    Optimizing Maternal RSV Immunization Delivery: A Systems-Based QI Initiative to Improve Uptake, Equity, and Newborn Outcomes
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines USA
    Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)
    Release Date:
    Partner: Astellas
    Review Process: Expert Review Panel
    Education Oncology All
    Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting Professorship
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology USA
    Improving Venous Thromboembolism (VTE) Diagnosis and Treatment with Primary Care Settings- A Quality Improvement Project
    Release Date:
    Partner: American Academy of Family Physicians
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Cardiac Transthyretin Amyloid (ATTR) Fellowship
    Release Date:
    Partner: International Society of Amyloidosis
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital All
    Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets Asia
    Release Date:
    Partner: RCNi
    Review Process: Expert Review Panel
    Education Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Improving Real-World Evidence & Data Generation Skills in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Education Support for the Professions All
    Optimizing Venous Thromboembolism Management in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine All
    Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited Settings
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Increase HCP knowledge of Gene Therapy management
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease China
    Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All
    Pre-clinical & Translational Research in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Best Practices in HR+HER2-Metastatic Breast Cancer Medical Management Latin America,Africa,Middle East,Asia Pacific except China
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Acute Lymphoblastic Leukemia Peer-to-Peer Education & Support
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Patient Access to CDK 4/6 Inhibitors in the Armamentarium Against Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Understanding healthcare disparities in Atopic Dermatitis and Alopecia Areata patients
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology All
    ADVANCE: Global Awards for Advancing Chronic Pain Research
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Enhancing the Understanding of Health Maintenance in the Management of IBD
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Outpatient Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Tajikistan, Turkey, Turkmenistan, Ukraine, United Kingdom, Uzbekistan
    Emerging Therapies in Alopecia Areata for Dermatologists - United States
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Virtual Programs for Rheumatology Education
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2021/2022 Global NASH ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Addressing Knowledge Gaps in Alopecia Areata and Atopic Dermatitis (Global (excluding the US)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    2021/2022 Global Obesity ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Advances in Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Geriatric Anorexia – Educational Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    2021/2022 Global Cachexia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Closing Knowledge Gaps in Moderate-to-Severe Atopic Dermatitis for Allergists
    Release Date:
    Partner: American College of Allergy, Asthma & Immunology (ACAAI)
    Review Process: Expert Review Panel
    Education Inflammation & Immunology USA
    Emerging Therapies for Atopic Dermatitis and Alopecia Areata for Advanced Practice Providers and Primary Care Physicians
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Pediatric Growth Hormone Deficiency Education
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    2021 I&I RE-CUP-IT REal world data Competitive grant in Ulcerative colitis Program - ITalian experiences
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
    Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Cardiac Amyloidosis Mentor mATTch pRogram
    Release Date:
    Partner: Amyloidosis Foundation
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Antimicrobial Stewardship (AMS) Programs in USA, Europe, Japan, South Korea, Australia and New Zealand
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Assessing Gaps in BRAF Testing in Melanoma & Colorectal Cancer in Developing Regions
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Algeria, Argentina, Brazil, Colombia, Iraq, Kuwait, Lebanon, Mexico, Qatar, Saudi Arabia, United Arab Emirates
    Astellas and Pfizer Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Telehealth Use in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Internal Medicine Canada
    Improving ATTR Amyloidosis Management in Spain
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Spain
    Equity in Access to Rare Disease Clinical Trials
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Management of Endometriosis
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    2022 Inflammatory Bowel Disease (IBD) Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    2022 IBD Competitive Grant Program
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Establishment of an Appropriate Network of Medical Care and Education for Axial Spondyloarthritis
    Release Date:
    Partner: The Japan Spondyloarthritis Society
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    2022 Hemophilia ASPIRE-Africa Middle East, Asia-Pacific, & Latin America
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    2022 Global Hemophilia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Management of Uterine Fibroids and Endometriosis
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    2022 Fellowship for Inflammatory Dermatological Diseases
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    2022 Rheumatology Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA